Delivery Order SPE2DB22D1002-SPE2DB24FLHX2

Award Date 9/16/24
Potential Completion Date 9/17/24
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a prescription medication. The contract has a ceiling value of $4,936.67 and an ultimate completion date of September 17, 2024. It is a firm fixed-price contract without any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a medical product, with a ceiling value of $1,384.20 and a completion date of March 20, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a specialty pharmaceutical product. The contract has a ceiling value of $1,397.04 and a period of performance through March 12, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $12,610.22, is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a medication used for diabetes management. The contract has a firm fixed price pricing type and an ultimate completion date of November 25, 2024. This contract is part of a larger Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide TRESIBA FLEXTOUCH 200 UNIT/ML 3ML. The contract has a ceiling value of $7,331.88 and a performance period through July 9, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,421.63, is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a pharmaceutical product. The contract has an ultimate completion date of March 5, 2025 and uses a Firm Fixed Price pricing type. AmerisourceBergen Drug Corp is the prime contractor, and the contract was not set aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML pharmaceutical products, with a ceiling value of $1,348.08. The contract is a firm-fixed price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a diabetes treatment medication, with a ceiling value of $2,141.37 and a period of performance extending to June 12, 2025. The contract is a firm fixed-price delivery order and is not a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,987.26, is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a specialty medication product. The contract has an ultimate completion date of February 3, 2025 and is a firm fixed-price agreement. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a pharmaceutical product, with a ceiling value of $1,392.98 and a period of performance ending on April 4, 2025. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FLHX2
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a prescription pharmaceutical product. The contract has a ceiling value of $5,278.86 and a completion date of September 17, 2024. The contract is a Firm-Fixed-Price type and is not associated with any set-aside program. AmerisourceBergen, as the prime contractor, will be responsible for delivering the required pharmaceutical product to support military treatment facilities and other federal healthcare providers nationwide. This contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a wide range of medical commodities to the U.S. government.

Generated 12/16/24, 2:16 PM